| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3871501 | The Journal of Urology | 2009 | 6 Pages |
Abstract
Sunitinib is effective in patients with pancreatic metastasis. This raises the question of whether patients with metastatic renal cell carcinoma limited to the pancreas may derive greater clinical benefit from anti-angiogenic agents, rather than from aggressive surgical resection. However, surgery remains the only potential cure in patients with isolated pancreatic metastasis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jacques Medioni, Toni K. Choueiri, Franck Zinzindohoué, Daniel Cho, Laure Fournier, Stephane Oudard,